UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 30

Sortiert nach

HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture

AIDS (London), 2006-06, Vol.20 (9), p.F9-F13

2006

Volltextzugriff (PDF)

In Vitro Resistance Profile of the Candidate HIV-1 Microbicide Drug Dapivirine

Antimicrobial Agents and Chemotherapy, 2012-02, Vol.56 (2), p.751-756

2012

Volltextzugriff (PDF)

Characterization of the E138K Resistance Mutation in HIV-1 Reverse Transcriptase Conferring Susceptibility to Etravirine in B and Non-B HIV-1 Subtypes

Antimicrobial Agents and Chemotherapy, 2011-02, Vol.55 (2), p.600-607

2011

Volltextzugriff (PDF)

Signature Nucleotide Polymorphisms at Positions 64 and 65 in Reverse Transcriptase Favor the Selection of the K65R Resistance Mutation in HIV-1 Subtype C

The Journal of infectious diseases, 2009-10, Vol.200 (8), p.1202-1206

2009

Volltextzugriff (PDF)

HIV gp120 H375 Is Unique to HIV-1 Subtype CRF01_AE and Confers Strong Resistance to the Entry Inhibitor BMS-599793, a Candidate Microbicide Drug

Antimicrobial Agents and Chemotherapy, 2012-08, Vol.56 (8), p.4257-4267

2012

Volltextzugriff (PDF)

Basis for Early and Preferential Selection of the E138K Mutation in HIV-1 Reverse Transcriptase

Antimicrobial Agents and Chemotherapy, 2013-10, Vol.57 (10), p.4681-4688

2013

Volltextzugriff (PDF)

Detection of Human Immunodeficiency Virus (HIV) Type 1 M184V and K103N Minority Variants in Patients with Primary HIV Infection

Antimicrobial Agents and Chemotherapy, 2009-04, Vol.53 (4), p.1670-1672

2009

Volltextzugriff (PDF)

Variations in Reverse Transcriptase and RNase H Domain Mutations in Human Immunodeficiency Virus Type 1 Clinical Isolates Are Associated with Divergent Phenotypic Resistance to Zidovudine

Antimicrobial Agents and Chemotherapy, 2007-11, Vol.51 (11), p.3861-3869

2007

Volltextzugriff (PDF)

HIV-1 Protease Codon 36 Polymorphisms and Differential Development of Resistance to Nelfinavir, Lopinavir, and Atazanavir in Different HIV-1 Subtypes

Antimicrobial Agents and Chemotherapy, 2010-07, Vol.54 (7), p.2878-2885

2010

Volltextzugriff (PDF)

Nucleoside and Nucleotide Analogs Select in Culture for Different Patterns of Drug Resistance in Human Immunodeficiency Virus Types 1 and 2

Antimicrobial Agents and Chemotherapy, 2009-02, Vol.53 (2), p.708-715

2009

Volltextzugriff (PDF)

Genetic Divergence of Human Immunodeficiency Virus Type 1 Ethiopian Clade C Reverse Transcriptase (RT) and Rapid Development of Resistance against Nonnucleoside Inhibitors of RT

Antimicrobial Agents and Chemotherapy, 2002-07, Vol.46 (7), p.2087-2094

2002

Volltextzugriff (PDF)

Apricitabine Does Not Select Additional Drug Resistance Mutations in Tissue Culture in Human Immunodeficiency Virus Type 1 Variants Containing K65R, M184V, or M184V plus Thymidine Analogue Mutations

Antimicrobial Agents and Chemotherapy, 2009-04, Vol.53 (4), p.1683-1685

2009

Volltextzugriff (PDF)

Soluble Urokinase Plasminogen Activator Receptor Is Predictive of Non-AIDS Events During Antiretroviral Therapy-mediated Viral Suppression

Clinical infectious diseases, 2019-08, Vol.69 (4), p.676-686

2019

Volltextzugriff (PDF)

Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus

Clinical infectious diseases, 2022-01, Vol.74 (1), p.95-104

2022

Volltextzugriff (PDF)

Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection

Clinical infectious diseases, 2023-07, Vol.77 (2), p.272-279

2023

Volltextzugriff (PDF)

High Rates of Forward Transmission Events after Acute/Early HIV-1 Infection

The Journal of infectious diseases, 2007-04, Vol.195 (7), p.951-959

2007

Volltextzugriff (PDF)

Evolution of a novel pathway leading to dolutegravir resistance in a patient harbouring N155H and multiclass drug resistance

Journal of antimicrobial chemotherapy, 2015-02, Vol.70 (2), p.405-411

2015

Volltextzugriff (PDF)

Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors

Journal of medical virology, 2011-05, Vol.83 (5), p.751-759

2011

Volltextzugriff (PDF)

Transmission Clustering Drives the Onward Spread of the HIV Epidemic Among Men Who Have Sex With Men in Quebec

The Journal of infectious diseases, 2011-10, Vol.204 (7), p.1115-1119

2011

Volltextzugriff (PDF)

A Randomized Placebo Controlled Trial of Aspirin Effects on Immune Activation in Chronically Human Immunodeficiency Virus-Infected Adults on Virologically Suppressive Antiretroviral Therapy

Open forum infectious diseases, 2017-01, Vol.4 (1), p.ofw278-ofw278

2017

Volltextzugriff (PDF)

Association of Cytomegalovirus Serostatus With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responsiveness in Nursing Home Residents and Healthcare Workers

Open forum infectious diseases, 2023-02, Vol.10 (2), p.ofad063-ofad063

2023

Volltextzugriff (PDF)

Association of Soluble Markers of Inflammation With Peri-coronary Artery Inflammation in People With and Without HIV Infection and Without Cardiovascular Disease

Open forum infectious diseases, 2023-08, Vol.10 (8), p.ofad328-ofad328

2023

Volltextzugriff (PDF)

Transmission dynamics of the M184V drug resistance mutation in primary HIV infection

Journal of antimicrobial chemotherapy, 2011-10, Vol.66 (10), p.2346-2349

2011

Volltextzugriff (PDF)

Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV Infection

Open forum infectious diseases, 2021-06, Vol.8 (6), p.ofab245-ofab245

2021

Volltextzugriff (PDF)

Variability in the PR and RT Genes of HIV-1 Isolated from Recently Infected Subjects

Antiviral chemistry & chemotherapy, 2004-10, Vol.15 (5), p.255-259

2004

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

KollektionIngentaConnect

ThemaInfectious Diseases

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(27)
Microbiology
(27)
Science & Technology
(27)
Humans
(23)
Hiv-1 - Genetics
(19)
Biological And Medical Sciences
(18)
Medical Sciences
(18)
Human Immunodeficiency Virus 1
(17)
Human Viral Diseases
(15)
Pharmacology & Pharmacy
(15)
Viral Diseases
(15)
Anti-Hiv Agents - Pharmacology
(14)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(14)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(13)
Hiv-1
(13)
Pharmacology. Drug Treatments
(13)
Mutation
(12)
Antiviral Agents
(11)
Drug Resistance, Viral
(11)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

HIV-1 subtype C viruses rapidly develop K65R resistance to tenofovir in cell culture

In Vitro Resistance Profile of the Candidate HIV-1 Microbicide Drug Dapivirine

Characterization of the E138K Resistance Mutation in HIV-1 Reverse Transcriptase Conferring Susceptibility to Etravirine in B and Non-B HIV-1 Subtypes

Signature Nucleotide Polymorphisms at Positions 64 and 65 in Reverse Transcriptase Favor the Selection of the K65R Resistance Mutation in HIV-1 Subtype C

HIV gp120 H375 Is Unique to HIV-1 Subtype CRF01_AE and Confers Strong Resistance to the Entry Inhibitor BMS-599793, a Candidate Microbicide Drug

Basis for Early and Preferential Selection of the E138K Mutation in HIV-1 Reverse Transcriptase

Detection of Human Immunodeficiency Virus (HIV) Type 1 M184V and K103N Minority Variants in Patients with Primary HIV Infection

Variations in Reverse Transcriptase and RNase H Domain Mutations in Human Immunodeficiency Virus Type 1 Clinical Isolates Are Associated with Divergent Phenotypic Resistance to Zidovudine

HIV-1 Protease Codon 36 Polymorphisms and Differential Development of Resistance to Nelfinavir, Lopinavir, and Atazanavir in Different HIV-1 Subtypes

Nucleoside and Nucleotide Analogs Select in Culture for Different Patterns of Drug Resistance in Human Immunodeficiency Virus Types 1 and 2

Genetic Divergence of Human Immunodeficiency Virus Type 1 Ethiopian Clade C Reverse Transcriptase (RT) and Rapid Development of Resistance against Nonnucleoside Inhibitors of RT

Apricitabine Does Not Select Additional Drug Resistance Mutations in Tissue Culture in Human Immunodeficiency Virus Type 1 Variants Containing K65R, M184V, or M184V plus Thymidine Analogue Mutations

Soluble Urokinase Plasminogen Activator Receptor Is Predictive of Non-AIDS Events During Antiretroviral Therapy-mediated Viral Suppression

Randomized Trial of Ruxolitinib in Antiretroviral-Treated Adults With Human Immunodeficiency Virus

Interleukin 6 Blockade With Tocilizumab Diminishes Indices of Inflammation That Are Linked to Mortality in Treated Human Immunodeficiency Virus Infection

High Rates of Forward Transmission Events after Acute/Early HIV-1 Infection

Evolution of a novel pathway leading to dolutegravir resistance in a patient harbouring N155H and multiclass drug resistance

Subtype diversity associated with the development of HIV-1 resistance to integrase inhibitors

Transmission Clustering Drives the Onward Spread of the HIV Epidemic Among Men Who Have Sex With Men in Quebec

A Randomized Placebo Controlled Trial of Aspirin Effects on Immune Activation in Chronically Human Immunodeficiency Virus-Infected Adults on Virologically Suppressive Antiretroviral Therapy

Association of Cytomegalovirus Serostatus With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responsiveness in Nursing Home Residents and Healthcare Workers

Association of Soluble Markers of Inflammation With Peri-coronary Artery Inflammation in People With and Without HIV Infection and Without Cardiovascular Disease

Transmission dynamics of the M184V drug resistance mutation in primary HIV infection

Changes in Immune Activation During Pregnancy and the Postpartum Period in Treated HIV Infection

Variability in the PR and RT Genes of HIV-1 Isolated from Recently Infected Subjects

Aktive Filter

Suchergebnisse filtern